{"abdominal pain upper": 2.16, "blast crisis in myelogenous leukaemia": 156.21, "chronic graft versus host disease": 46.58, "chronic myeloid leukaemia": 96.42, "chronic myeloid leukaemia recurrent": 157.6, "cytogenetic analysis abnormal": 536.0, "cytopenia": 26.6, "dermatitis allergic": 2.73, "disease progression": 4.52, "drug ineffective": 2.09, "drug interaction": 2.57, "drug intolerance": 17.3, "drug resistance": 56.02, "dyspepsia": 2.14, "eyelid oedema": 7.49, "face oedema": 4.65, "febrile neutropenia": 2.54, "fluid retention": 5.98, "gastrointestinal stromal tumour": 252.36, "gene mutation": 45.28, "generalised oedema": 12.05, "haematotoxicity": 20.09, "hepatotoxicity": 5.8, "maligt neoplasm progression": 11.98, "metastases to liver": 19.76, "muscle spasms": 2.73, "myelosuppression": 2.05, "neoplasm progression": 2.46, "neurotoxicity": 4.59, "neutropenia": 2.33, "oedema": 4.96, "oedema peripheral": 3.11, "pancytopenia": 5.26, "pericardial effusion": 3.46, "periorbital oedema": 18.75, "philadelphia chromosome positive": 217.24, "pleural effusion": 3.56, "pneumonitis": 2.29, "product substitution issue": 11.67, "second primary maligcy": 20.63, "splenomegaly": 6.64, "therapeutic response decreased": 6.75, "therapy non-responder": 9.96, "thrombocytopenia": 2.6, "treatment failure": 12.56, "type 2 diabetes mellitus": 5.45, "white blood cell count increased": 3.42}